Starpharma Holdings leading pharmaceutical development product is Vivagel®, a vaginal microbicide designed to inhibit the transmission of sexually transmitted infections, including HIV and genital herpes. Australian giant showed cash reserves of AUS$ 24.3million (about $21 million US) at the end of December 2009. [...]